Earnings · US stocks
Arrowhead Pharmaceuticals, Inc. (ARWR) earnings
Arrowhead Pharmaceuticals, Inc. published its quarterly report on 2026-11-12. The stock moved -8.82% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-12
- Result
- Bad / loss
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.34% | — |
| 3 days | -8.82% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 3 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +3.07%).
| Published | EPS YoY | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|
| 2026-11-12 | — | -1.52 | -1.20% | -8.82% | — | — |
| 2026-08-04 | — | -1.36 | -10.35% | -2.17% | -26.57% | -24.33% |
| 2026-05-07 | -133.80% | -0.93 | +15.98% | +1.40% | +5.20% | +3.44% |
| 2026-02-05 | — | 0.22 | +159.86% | -2.66% | -12.86% | -8.57% |
| 2025-11-25 | — | -0.18 | -14.45% | +20.22% | +37.98% | +35.16% |
| 2025-08-07 | — | -1.26 | -14.41% | +10.83% | +91.10% | +86.12% |
| 2025-05-12 | — | 2.75 | +695.04% | +9.81% | +12.10% | +7.96% |
| 2025-02-10 | — | -1.39 | -92.16% | -4.07% | -26.05% | -21.20% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.